Alert detail

LCD L33826: Oral Anticancer Drugs — DME MAC

Policy ID: LCD-L33826Specialty: OncologyAdded: 7/13/2026Effective: 2026-01-01lcd

Routine

What changed

DME MAC LCD for oral anticancer drugs effective Jan 1, 2026.

Who’s affected: Oncology billing teams · Effective: 2026-01-01

Affected codes

CodesJ8999 J8501 J8510 J8530 J8560

DxC80.1 C34.90 C50.919 C61 C18.9

Primary source: View the official CMS/MAC document ↗

Get the action steps and full analysis

This change affects 10 billing codes.

Subscribers get the recommended action (“what to do”), the full AI analysis, the LCD revision comparison, and related alerts across your specialty and jurisdiction.

View subscription plans Create a free account

Not ready to subscribe?

Get the free weekly reimbursement brief for Oncology— the week’s changes and deadlines, delivered to your inbox. No account required.